IMI PBM Sanitary Multiport Ball Valves
Overview:
- Series 5, Sizes 1/2" - 4"
- Materials: 316L, low ferrite cast and forged, Hastelloyª, others available
- End Connections: Extended tube, hygienic clamp, others
- Valves shall have 4 or 5 V-TEF or S-TEFseats and seals
- Working Pressures: up to 275 psig (19 bar) depending temperatures
- Temperature Range: up to 450ºF (232.2ºC), depending on seat and seal material
- Cv Values (gpm): 2.5 to 570 depending on end connection*
- ASME BPE Compliant
- Valves are rated for full vacuum.
- Variety of mechanical polish finishes as well as electropolish
- US, DIN, ISO True-Bore¨ Port Diameters
- USP Class VI elastomers and FDA complaint materials
- Certified Material Test Reports (CMTRS) provided for wetted components
Related Products
At Liquidyne, we prioritize our commitment to quality and consistency. In 2017 we achieved ISO 9001:2015 Quality Management System certification to ensure we can repeatedly deliver consistently high-quality products and solutions. Being an ISO 9001 facility, together with our USP Class VI Testing, ASME Bioprocessing Equipment (BPE), and EHEDG certification guarantee, we have the methodologies to assure quality. We will quickly and accurately rectify any issues if any of our products are ever in non-conformance.
"Thanks so much! What a quick turn around. It is a pleasure working with Liquidyne."
Process Development Manager
"I received the cart yesterday, thanks for the fast delivery! It feels sturdy. I sat on it. It does not bounce. It is also easy to clean and wipe or wash down."
Vice President, Analytical Development and Manufacturing
"Thanks again for reacting so quickly and meeting me halfway with the element. We will be able to get installed and have things keep moving overnight with the night crew. The little things like this are always greatly appreciated when working with Liquidyne."
Chemical Engineer
“This pump cut our processing time from 3 days to 1 shift. I’m not giving this pump back. You will have to come and get it if you want it... and that won’t likely happen.”
VP Antibody Manufacturing